ReSolution Latin America
Martin Miglio is an accomplished finance and administration professional with extensive experience across various companies in Latin America. Currently serving as the Director of Finance and Administration at ReSolution Latin America since May 2023, Martin leads finance activities and participates in ERP implementation while ensuring compliance with local and corporate GAAP. Prior roles include Accounting Manager at Syneos Health, where responsibilities encompassed accounting closes and corporate reporting for Latin America, and a series of management positions at PAREXEL, focusing on corporate accounting, statutory compliance, and process improvements in Brazil and Mexico. Earlier in their career, Martin held leadership positions at Thomson Reuters and Nokia, managing financial operations and accounting teams. Martin Miglio holds a degree in Contador Público from the University of Buenos Aires.
This person is not in any teams
This person is not in any offices
ReSolution Latin America
ReSolution Latin America is a clinical research solutions provider completely specialized in supporting our sponsors with their clinical development programs in the Latin American region. We provide our Sponsors with the opportunity to work with a credible regional niche CRO provider that is able to successfully: • Understand the expectations of international clients, as well as the requirements and demands of international clinical protocols. • Work locally and regionally to execute and deliver to these standards ensuring that the data that stems from Latin America can be integrated into the global data sets and used by our Sponsors for international regulatory purposes. Our expertise and infrastructure across the Latin American region enables us to offer our Sponsors access to all the advantages the region has to offer for clinical development (quality data, high enrollment potential, shortening of development timelines and cost) whilst minimizing potential pitfalls. Working exclusively through our own, fully-owned legal entities and with our own staff (no contractors/freelancers)- since our inception in 2007- we have enrolled in the region of 14,000 study participants across the board in terms of therapeutic areas, disease-types, product types and study complexities. We understand local and regional idiosyncrasies in a region where one size does not fit all.